FindTrial
Sign In

The Need for Luteal Support in NC-FET

The Use of Luteal Support After NC-FET

Status
UNKNOWN
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01483365
Enrollment
100
Registered
2011-12-01
Start date
2011-12-31
Completion date
2014-12-31
Last updated
2014-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abnormal Menstrual Cycle

Brief summary

The investigators are going to examine prospectively the need of luteal support after NC-FET.

Detailed description

The investigators are going to examine retroprospectively the need of luteal support after NC-FET in IVF cycle. One arm will receive luteal support after NC FET with vaginal tablet of Endometrin 100 mg twice a day after ET. The second arm will not. We are going to evaluate the pregnancy and implantation rate.

Interventions

DRUGVaginal tablet Endometrin twice a day

Endometrin 100 mg twice a day

Sponsors

Wolfson Medical Center
Lead SponsorOTHER_GOV

Study design

Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 39 Years
Healthy volunteers
No

Inclusion criteria

* Women under 39 years old, regular menstruation going through IVF NC-FET

Exclusion criteria

* NO

Design outcomes

Primary

MeasureTime frameDescription
Pregnancy rate4 weeksWe would like to investigate whether there is need for luteal support in NC-FET cycle.

Countries

Israel

Contacts

Primary ContactEran Horowitz, M.D
ERANH7@GMAIL.COM972-3-5028105

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026